Enveric Biosciences, Inc. (ENVB) Earnings History
Annual and quarterly earnings data from 1994 to 2024
Loading earnings history...
ENVB EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
ENVB Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
Download Data
Export ENVB earnings history in CSV or JSON format
Free sign-in required to download data
Enveric Biosciences, Inc. (ENVB) Earnings Overview
As of May 8, 2026, Enveric Biosciences, Inc. (ENVB) reported trailing twelve-month net income of -$10M, reflecting -135.4% year-over-year growth. The company earned $-31.07 per diluted share over the past four quarters.
Looking at the long-term picture, ENVB's historical earnings data spans multiple years. The company achieved its highest annual net income of $807,276 in fiscal 2007.
Enveric Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CMPS (-$288M net income), MNMD (-$238M net income), ATAI (-$154M net income, -48464.0% margin), ENVB has comparable earnings metrics. Compare ENVB vs CMPS →
ENVB Earnings vs Peers
Earnings metrics vs comparable public companies
ENVB Historical Earnings Data (1994–2024)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$10M | -55272.4% | -$10M | $-228.48 | - | - |
| 2023 | $-17,292 | +99.9% | -$16M | $-97.08 | - | - |
| 2022 | -$19M | +62.2% | -$20M | $-156.00 | - | - |
| 2021 | -$49M | -613.5% | -$26M | $-1244.28 | - | - |
| 2020 | -$7M | -22.5% | -$6M | $-666.00 | - | - |
| 2019 | -$6M | +66.8% | -$6M | $-2543.88 | -14.0% | -15.8% |
| 2018 | -$17M | -86.2% | -$7M | $-42616.68 | -39.3% | -16.6% |
| 2017 | -$9M | -226.4% | -$12M | $-36347.76 | -18.7% | -24.6% |
| 2016 | -$3M | -47.1% | -$5M | $-12770.04 | -7.7% | -14.9% |
| 2015 | -$2M | -5519.9% | -$2M | $-10220.28 | -11.8% | -11.7% |
See ENVB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ENVB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ENVB vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonENVB — Frequently Asked Questions
Quick answers to the most common questions about buying ENVB stock.
Is ENVB growing earnings?
ENVB EPS fell to $-31.07, with earnings declining -135.4%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-10M.
What are ENVB's profit margins?
Enveric Biosciences, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ENVB's earnings?
ENVB earnings data spans 1994-2024. The declining earnings trend is -135.4% YoY. Historical data enables comparison across business cycles.